Sufentanil Stocks List
|XPH||D||SPDR S&P Pharmaceuticals ETF||0.19|
|PQSG||B||PGIM QMA Strategic Alpha Small-Cap Growth ETF||0.15|
|PILL||F||Direxion Daily Pharmaceutical & Medical Bull 3X Shares||0.14|
|IWC||D||iShares Microcap ETF||0.11|
|STSB||B||iShares Factors US Small Blend Style ETF||0.07|
View all Sufentanil related ETFs...
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times more potent than its parent drug, fentanyl, and 500 times as potent as morphine. Structurally, sufentanil differs from fentanyl through the addition of a methoxymethyl group on the piperidine ring (which is believed to reduce duration of action), and the replacement of the phenyl ring by thiophene. Sufentanil first was synthesized at Janssen Pharmaceutica in 1974.Sufentanil is marketed for use by specialist centers under different trade names, such as Sufenta and Sufentil. Sufentanil with and without lidocaine or mepivacaine is available as a transdermal patch similar to Duragesic in Europe under trade names such as Chronogesic. It is available as a sublingual tablet under the trade name Dsuvia.